Exchange: NASDAQ·Updated 07:37 PM EST
NKTX logo

NKTX Nkarta Inc

$1.10
$0.015
(1.34%)
Today
Closed $1.14
$0.0326
(2.87%)
After Hours
Reported EarningsNov 5
Mkt Cap$81.38M
Vol1.6M

About NKTX

Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm’s product include NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes, and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA.
25

Bearish Sentiment

How do you feel about NKTX?

ContrarianValue
$NKTX Bullish purely based on the fact that this is a specialized engineered off the shelf Car-NK treatment that was safe in 40 individuals with 0 side-effects reported. It is outpatient, and effective in two indications. Which sets up for a wonderful chance at approval in the next phase via a priority award.
1
4
Q12021Dreaming
$NKTX Seems like positive results from what I'm reading on social media and if you combine that with medical sector sentiment, this just might be a top runner tomorrow.
1
4
AlertsAndNews
$NKTX looks like they're dropping data on Monday. heres the PR Nkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026 "today announced that it will host a webcast on Monday, November 9, 2026, at 8:00 a.m. ET, to review initial clinical data from its Ntrust program evaluating NKX019 in myositis and systemic sclerosis being presented at the American College of Rheumatology (ACR) Convergence 2026 in Orlando."
7
Golibajje
$NKTX There are a lot of shorts piled up on this! whether the news is good or bad, they are going to short this brutally tomorrow and will take it to $1.40 area! mainly to get rid of short term traders! I am personally bullish on this company, but for long term! buy those cheapies and hold for 1-2 years! could be 500%+ Anything under $2 is a great buy here!
2
allllll
$NKTX Unbelievable how cheap this stock is. Trading at 0.5x cash value with decent efficiency and safety results already published, two accepted oral talks at the conference and great scientists backing up the science. It’s worth 10$ ar least.
5
allllll
$NKTX At $1.60 Nkarta’s market cap is about $119M against roughly $207M of estimated cash. That’s about $87M below cash, or 0.58x. The pipeline is again valued at clearly less than zero.
1
2
youbi336
$NKTX There is this manufactured contrariety in the market that tries to hide the value of things and shake insecure investors/traders. The only way to fight it is to trade with value in mind and ignore weird price action. Efficacy is good. Safety is good. Value is great. Buy. Ignore. Wait.
4
theroverriver
$NKTX So glad I bought another 1500 shares at 1.52. AH session is currently at $1.95 hopefully it has a leg up on Monday.
4
youbi336
$NKTX According to the 10-Q, it seems like they chose myositis and scleroderma as their main indications
4
youbi336
$NKTX It seems like both Nkarta and $FATE got hammered after sharing good data. WTH is wrong with this market?!
3
SharkAttack1
$NKTX more broadly with a tickle of efficacy and a clean so far safety profile the mcap and cash position has to make NKTX attractive for a big cap pharma with experience in cellular therapies to take a punt on this… risk reward would seem very favourable…
3
Lukey63
$NKTX I have roughly 25 developmental stage Bio’s in my portfolio or watch list. With this massacre NKTX is now the 3rd cheapest on a price to cash and TBV basis. Of the other two, one is more speculative with a shorter runway, the other is promising with a much shorter runway. Many are trading at a premium to NKTX despite not nearly the runway and no better prospects, IMO.
3
allllll
$NKTX The most hated stock on the market, complete nonsense. It’s now 0.4x cash value and the clinical results are truly positive.
3
lovestockstwits
$NKTX is anyone even on this board ..why this one still exist if no one even cares with data in a week ..
3
Spaceshipboom
$NKTX started a position today .. hopefully it’s the right time.. let me know your thoughts folks :)
3
Lukey63
$NKTX here is a partial list of “smart money” long this company as of 6/30 - BlackRock, Vanguard, Citadel, Renaissance, Millennium and AQR - known as one of the most astute value HFs around. Tang dumped it. We shall see with 9/30 but this is a strong list of longs. I like to follow the SM and see what they are doing and this gives me some confidence.
2
Lukey63
$NKTX who is selling down here? And who is allowing their shares to be borrowed to short?
2
Rayvio_News_Filter
$NKTX 🏥 Nkarta, Inc. reported initial clinical data for NKX019 in myositis and systemic sclerosis, with 5/6 (83%) myositis patients and 6/7 (86%) systemic sclerosis patients achieving responses at 4 billion cells per dose.
2
Q12021Dreaming
$NKTX take a good look at the 30-day chart and note the pivot just after Tuesday's election results. Combine that with positive news and I'm speculating good things to come. 🤞🐂🤞
2
OriginalTradeonrumor
$NKTX strong day today …but we need a close above 1.90s to start getting excited … Let’s see what happens!
2

Advertisement|Remove ads.